These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3556155)

  • 41. Mode of uptake and degradation of 125I-labelled insulin by isolated hepatocytes and H4 hepatoma cells.
    Terris S; Hofmann C; Steiner DF
    Can J Biochem; 1979 Jun; 57(6):459-68. PubMed ID: 476501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells.
    McClain DA; Olefsky JM
    Diabetes; 1988 Jun; 37(6):806-15. PubMed ID: 2838354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism.
    Heaton JH; Gelehrter TD
    J Biol Chem; 1981 Dec; 256(23):12257-62. PubMed ID: 7028753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions between insulin and its receptors after the initial binding event. Functional heterogeneity and relationships to insulin degradation.
    Olefsky JM; Kobayashi M; Chang H
    Diabetes; 1979 May; 28(5):460-71. PubMed ID: 437375
    [No Abstract]   [Full Text] [Related]  

  • 45. Internalization and recycling of insulin receptors in hepatoma cells. Absence of regulation by receptor occupancy.
    Chvatchko Y; Van Obberghen E; Fehlmann M
    Biochem J; 1984 Aug; 222(1):111-7. PubMed ID: 6383354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of alkaline phosphatase activity in rat hepatoma cells. Effects of serum proteins, cycloheximide, actinomycin D, chloroquine, dinitrophenol and potassium cyanide.
    Sorimachi K; Yasumura Y
    Biochim Biophys Acta; 1986 Mar; 885(3):272-81. PubMed ID: 2418885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of specific association of insulin with HepG2 cells by phorbol esters.
    Blake AD; Strader CD
    Biochem J; 1986 May; 236(1):227-34. PubMed ID: 3539101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrastructural basis for chloroquine-induced increase in intracellular insulin in adipocytes: alteration of lysosomal function.
    Smith RM; Jarett L
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7302-6. PubMed ID: 6760194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory effect of cholecystokinin on subsequent insulin binding to pancreatic acini.
    Okabayashi Y; Otsuki M; Nakamura T; Koide M; Hasegawa H; Okutani T; Kido Y
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E562-8. PubMed ID: 2110419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-receptor interactions. Presence of a positive cooperative effect.
    Marsh JW; Westley J; Steiner DF
    J Biol Chem; 1984 May; 259(10):6641-9. PubMed ID: 6373763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential kinetics and sensitivity to chloroquine of receptor-mediated insulin and prolactin endocytosis in liver parenchymal cells.
    Khan MN; Savoie S; Bergeron JJ; Posner BI
    Biochim Biophys Acta; 1986 Aug; 888(1):100-6. PubMed ID: 3017440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
    Jochen A; Berhanu P
    Biochem Biophys Res Commun; 1987 Jan; 142(1):205-12. PubMed ID: 3545203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of insulin-binding to the hepatoma cell line H35.
    de Vries CP; van der Veen EA
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):559-64. PubMed ID: 3529787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fate of insulin in rat hepatocytes. Evidence for the release of an immunologically active fragment.
    Misbin RI; Almira EC
    Diabetes; 1984 Apr; 33(4):355-61. PubMed ID: 6368292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of down regulation by chloroquine in cultured lymphocytes (RPMI-1788 line).
    Maegawa H; Kobayashi M; Watanabe N; Ishibashi O; Takata Y; Shigeta Y
    Diabetes Res Clin Pract; 1985 Oct; 1(3):145-53. PubMed ID: 3915261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line.
    Pun KK; Lau P; Ho PW
    J Bone Miner Res; 1989 Dec; 4(6):853-62. PubMed ID: 2692404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of estradiol on insulin receptor distribution in primary cultures of R3230AC mammary adenocarcinoma of the rat.
    Hilf R; Crofton DH
    Endocrinology; 1985 Jan; 116(1):154-63. PubMed ID: 3880538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin receptors in Zajdela rat ascites hepatoma cells and their sensitivity to certain enzymes and lectins.
    Capeau J; Picard J; Caron M
    Cancer Res; 1978 Nov; 38(11 Pt 1):3930-7. PubMed ID: 698942
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative studies on insulin-like growth factor II and insulin processing by vascular endothelial cells.
    Hachiya HL; Carpentier JL; King GL
    Diabetes; 1986 Oct; 35(10):1065-72. PubMed ID: 2944781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.